Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pharmanet Names Dr. George Scott Vice President of Bioanalytical Services

Published: Friday, July 22, 2011
Last Updated: Friday, July 22, 2011
Bookmark and Share
Dr. Scott will provide leadership for PharmaNet's GLP-compliant bioanalytical laboratories in the United States and Canada.

PharmaNet Development Group, Inc., has announced that it has appointed George Scott, PhD, as Vice President, Bioanalytical Services.

In this role, Dr. Scott will provide leadership for PharmaNet's GLP-compliant bioanalytical laboratories in the United States and Canada.

In addition, he will build upon PharmaNet's bioanalytical method development, validation and sample analysis services across the continuum of drug development and lead PharmaNet's geographical and service expansion strategies in bioanalysis.

"Dr. Scott has a very impressive scientific and operational experience base in bioanalysis," commented Riaz Bandali, President, Early Stage Development. "He has extensive knowledge of our clients' needs and is highly regarded in the industry for his scientific expertise and his business acumen."

Prior to joining PharmaNet, Dr. Scott served as Director of Pharmacokinetics and Drug Metabolism at Amgen, a world leader in biotechnology. He was responsible for overseeing the immunochemistry and small molecule bioanalytical capabilities.

He was also integrally involved in the Amgen Leadership Committee that managed strategic outsourcing decisions for small molecule and large molecule programs to global bioanalytical service providers.

Prior to Amgen, Dr. Scott was responsible for establishing and growing the global ligand binding services at another CRO.

Dr. Scott holds a Bachelors of Science in Neuroscience from Edinburgh University and was awarded a PhD from the University of Nottingham for studies in neuropharmacology.

After four years in post-doctoral positions at Dalhousie University and the University of Montreal, he served for two years as an Assistant Professor in the faculty of Dentistry at McGill University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PharmaNet’s Bioanalytical Laboratory Recognized by the Standards Council of Canada for Good Laboratory Practice Compliance
OECD GLP recognition consolidates Company’s position as the partner of choice for companies seeking assured international registration of their products.
Wednesday, June 29, 2011
Valerie Palumbo Joins Pharmanet as Senior Vice President, Corporate Quality Assurance
Ms. Palumbo has more than twenty years of experience in the development and implementation of quality assurance programs in the FDA-regulated drug and medical device industries.
Tuesday, May 03, 2011
Pharmanet Appoint New Chief Medical Officer
PharmaNet Development Group, Inc. announces that Jeffrey Freitag, M.D., Senior Vice President, PharmaNet Consulting, will expand his role to become Chief Medical Officer of PharmaNet.
Monday, February 21, 2011
PharmaNet Launches New Brand Identity
PharmaNet Development Group, Inc. announced that it is launching a new brand identity and tagline, “PharmaNet Works For You”. The new brand and tagline reflect the Company’s promise to its clients to provide intelligent solutions to accelerate drug development programs consistent with the highest standards of regulatory compliance, quality and reliability.
Thursday, November 25, 2010
PharmaNet Development Group Collaborates with Abacus International
Collaboration is aimed to support patient registries and health economic programs in Europe.
Monday, July 26, 2010
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!